beta-lapachone has been researched along with Candida Infection in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, CR | 1 |
| S Campos, R | 1 |
| de A Neto, JB | 1 |
| Sampaio, LS | 1 |
| do Nascimento, FB | 1 |
| do Av Sá, LG | 1 |
| Cândido, TM | 1 |
| Magalhães, HI | 1 |
| da Cruz, EH | 1 |
| da Silva Júnior, EN | 1 |
| de Moraes, MO | 1 |
| Cavalcanti, BC | 1 |
| Silva, J | 1 |
| Marinho, ES | 1 |
| Júnior, HV | 1 |
1 other study available for beta-lapachone and Candida Infection
| Article | Year |
|---|---|
Antifungal activity of β-lapachone against azole-resistant
Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbia | 2020 |